Selected research
Industry Research
Cellular Therapy Products Industry Research Report 2026
Market perspective
The global Cellular Therapy Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cellular Therapy Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cellular Therapy Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cellular Therapy Products include Beike Biotechnology, Fujifilm Cellular Dynamics, Gilead Sciences, Golden Meditech, Guanhao Biotech, JCR Pharmaceuticals, Osiris, Vcanbio and Vericel Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cellular Therapy Products market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cellular Therapy Products Market by Company
Beike Biotechnology
Fujifilm Cellular Dynamics
Gilead Sciences
Golden Meditech
Guanhao Biotech
JCR Pharmaceuticals
Osiris
Vcanbio
Vericel Corporation
Novartis
Cellular Therapy Products Segment by Type
Stem Cell Type
Non-Stem Cell Type
Cellular Therapy Products Segment by Application
Hospital
Clinic
Others
Cellular Therapy Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cellular Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cellular Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cellular Therapy Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cellular Therapy Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cellular Therapy Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cellular Therapy Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Type
- Non-Stem Cell Type
Applications
- Hospital
- Clinic
- Others
Companies covered
- Beike Biotechnology
- Fujifilm Cellular Dynamics
- Gilead Sciences
- Golden Meditech
- Guanhao Biotech
- JCR Pharmaceuticals
- Osiris
- Vcanbio
- Vericel Corporation
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cellular Therapy Products Market Size (2021-2032)
- 2.2.2 Global Cellular Therapy Products Sales (2021-2032)
- 2.2.3 Global Cellular Therapy Products Market Average Price (2021-2032)
- 2.3 Cellular Therapy Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Stem Cell Type
- 2.3.3 Non-Stem Cell Type
- 2.4 Cellular Therapy Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cellular Therapy Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cellular Therapy Products Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cellular Therapy Products Revenue of Manufacturers (2021-2026)
- 3.4 Global Cellular Therapy Products Average Price by Manufacturers (2021-2026)
- 3.5 Global Cellular Therapy Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cellular Therapy Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cellular Therapy Products, Product Type & Application
- 3.8 Global Manufacturers of Cellular Therapy Products, Established Date
- 3.9 Global Cellular Therapy Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Beike Biotechnology
- 4.1.1 Beike Biotechnology Company Information
- 4.1.2 Beike Biotechnology Business Overview
- 4.1.3 Beike Biotechnology Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Beike Biotechnology Cellular Therapy Products Product Portfolio
- 4.1.5 Beike Biotechnology Recent Developments
- 4.2 Fujifilm Cellular Dynamics
- 4.2.1 Fujifilm Cellular Dynamics Company Information
- 4.2.2 Fujifilm Cellular Dynamics Business Overview
- 4.2.3 Fujifilm Cellular Dynamics Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fujifilm Cellular Dynamics Cellular Therapy Products Product Portfolio
- 4.2.5 Fujifilm Cellular Dynamics Recent Developments
- 4.3 Gilead Sciences
- 4.3.1 Gilead Sciences Company Information
- 4.3.2 Gilead Sciences Business Overview
- 4.3.3 Gilead Sciences Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Gilead Sciences Cellular Therapy Products Product Portfolio
- 4.3.5 Gilead Sciences Recent Developments
- 4.4 Golden Meditech
- 4.4.1 Golden Meditech Company Information
- 4.4.2 Golden Meditech Business Overview
- 4.4.3 Golden Meditech Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Golden Meditech Cellular Therapy Products Product Portfolio
- 4.4.5 Golden Meditech Recent Developments
- 4.5 Guanhao Biotech
- 4.5.1 Guanhao Biotech Company Information
- 4.5.2 Guanhao Biotech Business Overview
- 4.5.3 Guanhao Biotech Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guanhao Biotech Cellular Therapy Products Product Portfolio
- 4.5.5 Guanhao Biotech Recent Developments
- 4.6 JCR Pharmaceuticals
- 4.6.1 JCR Pharmaceuticals Company Information
- 4.6.2 JCR Pharmaceuticals Business Overview
- 4.6.3 JCR Pharmaceuticals Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 JCR Pharmaceuticals Cellular Therapy Products Product Portfolio
- 4.6.5 JCR Pharmaceuticals Recent Developments
- 4.7 Osiris
- 4.7.1 Osiris Company Information
- 4.7.2 Osiris Business Overview
- 4.7.3 Osiris Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Osiris Cellular Therapy Products Product Portfolio
- 4.7.5 Osiris Recent Developments
- 4.8 Vcanbio
- 4.8.1 Vcanbio Company Information
- 4.8.2 Vcanbio Business Overview
- 4.8.3 Vcanbio Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Vcanbio Cellular Therapy Products Product Portfolio
- 4.8.5 Vcanbio Recent Developments
- 4.9 Vericel Corporation
- 4.9.1 Vericel Corporation Company Information
- 4.9.2 Vericel Corporation Business Overview
- 4.9.3 Vericel Corporation Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Vericel Corporation Cellular Therapy Products Product Portfolio
- 4.9.5 Vericel Corporation Recent Developments
- 4.10 Novartis
- 4.10.1 Novartis Company Information
- 4.10.2 Novartis Business Overview
- 4.10.3 Novartis Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novartis Cellular Therapy Products Product Portfolio
- 4.10.5 Novartis Recent Developments
5 Global Cellular Therapy Products Market Scenario by Region
- 5.1 Global Cellular Therapy Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cellular Therapy Products Sales by Region: 2021-2032
- 5.2.1 Global Cellular Therapy Products Sales by Region: 2021-2026
- 5.2.2 Global Cellular Therapy Products Sales by Region: 2027-2032
- 5.3 Global Cellular Therapy Products Revenue by Region: 2021-2032
- 5.3.1 Global Cellular Therapy Products Revenue by Region: 2021-2026
- 5.3.2 Global Cellular Therapy Products Revenue by Region: 2027-2032
- 5.4 North America Cellular Therapy Products Market Facts & Figures by Country
- 5.4.1 North America Cellular Therapy Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cellular Therapy Products Sales by Country (2021-2032)
- 5.4.3 North America Cellular Therapy Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cellular Therapy Products Market Facts & Figures by Country
- 5.5.1 Europe Cellular Therapy Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cellular Therapy Products Sales by Country (2021-2032)
- 5.5.3 Europe Cellular Therapy Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Cellular Therapy Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cellular Therapy Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cellular Therapy Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cellular Therapy Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cellular Therapy Products Market Facts & Figures by Country
- 5.7.1 South America Cellular Therapy Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cellular Therapy Products Sales by Country (2021-2032)
- 5.7.3 South America Cellular Therapy Products Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cellular Therapy Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cellular Therapy Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cellular Therapy Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cellular Therapy Products Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cellular Therapy Products Sales by Type (2021-2032)
- 6.1.1 Global Cellular Therapy Products Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cellular Therapy Products Sales Market Share by Type (2021-2032)
- 6.2 Global Cellular Therapy Products Revenue by Type (2021-2032)
- 6.2.1 Global Cellular Therapy Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cellular Therapy Products Revenue Market Share by Type (2021-2032)
- 6.3 Global Cellular Therapy Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cellular Therapy Products Sales by Application (2021-2032)
- 7.1.1 Global Cellular Therapy Products Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cellular Therapy Products Sales Market Share by Application (2021-2032)
- 7.2 Global Cellular Therapy Products Revenue by Application (2021-2032)
- 7.2.1 Global Cellular Therapy Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cellular Therapy Products Revenue Market Share by Application (2021-2032)
- 7.3 Global Cellular Therapy Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cellular Therapy Products Value Chain Analysis
- 8.1.1 Cellular Therapy Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cellular Therapy Products Production Mode & Process
- 8.2 Cellular Therapy Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cellular Therapy Products Distributors
- 8.2.3 Cellular Therapy Products Customers
9 Global Cellular Therapy Products Analyzing Market Dynamics
- 9.1 Cellular Therapy Products Industry Trends
- 9.2 Cellular Therapy Products Industry Drivers
- 9.3 Cellular Therapy Products Industry Opportunities and Challenges
- 9.4 Cellular Therapy Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst